AdaptHealth Corp. (NASDAQ:AHCO) Receives $13.40 Average PT from Brokerages

AdaptHealth Corp. (NASDAQ:AHCO) has been given a consensus rating of “Buy” by the five analysts that are covering the firm, Marketbeat reports. Five research analysts have rated the stock with a buy recommendation. The average 12-month price objective among brokerages that have issued a report on the stock in the last year is $13.40.

Several equities research analysts recently weighed in on AHCO shares. Wall Street Zen raised AdaptHealth from a “hold” rating to a “buy” rating in a report on Saturday, August 9th. Truist Financial decreased their price target on AdaptHealth from $14.00 to $13.00 and set a “buy” rating for the company in a report on Monday, May 12th.

Insider Buying and Selling at AdaptHealth

In related news, Director David Solomon Williams III sold 8,200 shares of the stock in a transaction on Friday, August 22nd. The stock was sold at an average price of $9.73, for a total transaction of $79,786.00. Following the completion of the sale, the director directly owned 50,045 shares of the company’s stock, valued at $486,937.85. This trade represents a 14.08% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. 1.55% of the stock is currently owned by corporate insiders.

Institutional Investors Weigh In On AdaptHealth

Hedge funds and other institutional investors have recently bought and sold shares of the business. AlphaQuest LLC lifted its holdings in AdaptHealth by 275.7% in the second quarter. AlphaQuest LLC now owns 3,941 shares of the company’s stock valued at $37,000 after acquiring an additional 2,892 shares during the period. Assetmark Inc. boosted its position in shares of AdaptHealth by 87.6% in the 2nd quarter. Assetmark Inc. now owns 5,529 shares of the company’s stock worth $52,000 after buying an additional 2,581 shares in the last quarter. GAMMA Investing LLC boosted its position in shares of AdaptHealth by 175.2% in the 1st quarter. GAMMA Investing LLC now owns 7,473 shares of the company’s stock worth $81,000 after buying an additional 4,758 shares in the last quarter. Brooklyn Investment Group boosted its position in shares of AdaptHealth by 531.8% in the 1st quarter. Brooklyn Investment Group now owns 7,563 shares of the company’s stock worth $82,000 after buying an additional 6,366 shares in the last quarter. Finally, Tower Research Capital LLC TRC boosted its position in shares of AdaptHealth by 318.0% in the 2nd quarter. Tower Research Capital LLC TRC now owns 9,592 shares of the company’s stock worth $90,000 after buying an additional 7,297 shares in the last quarter. Institutional investors and hedge funds own 82.67% of the company’s stock.

AdaptHealth Stock Performance

Shares of AHCO opened at $9.51 on Wednesday. The company has a current ratio of 1.06, a quick ratio of 0.82 and a debt-to-equity ratio of 1.14. The firm has a market cap of $1.29 billion, a PE ratio of 17.61, a price-to-earnings-growth ratio of 1.03 and a beta of 1.59. The company’s 50 day simple moving average is $9.33 and its 200-day simple moving average is $9.26. AdaptHealth has a 12-month low of $7.11 and a 12-month high of $11.70.

About AdaptHealth

AdaptHealth Corp., together with its subsidiaries, sells home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs.